Bigfoot Biomedical has been granted a patent for a reusable accessory for manual medication delivery devices. The accessory includes a wireless communication interface, detection circuitry, and a recommendation system. It can detect dosing events, track time since dosing, and provide medication dose recommendations based on analyte measurements. GlobalData’s report on Bigfoot Biomedical gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Bigfoot Biomedical Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Bigfoot Biomedical, Wearable drug delivery devices was a key innovation area identified from patents. Bigfoot Biomedical's grant share as of February 2024 was 36%. Grant share is based on the ratio of number of grants to total number of patents.

Smart reusable accessory for manual medication delivery device

Source: United States Patent and Trademark Office (USPTO). Credit: Bigfoot Biomedical Inc

A recently granted patent (Publication Number: US11918789B2) discloses a reusable accessory designed for manual medication delivery devices. The accessory includes a processor and computer-readable storage medium storing instructions that enable it to receive analyte measurement data from a sensor system, detect dosing events, store data related to these events, track time post-dosing, and provide medication dose recommendations based on the data and time elapsed since dosing. The accessory can be adapted to couple with the medication delivery device, communicate wirelessly with the sensor system, and detect dosing events using detection circuitry or sensors. It is particularly suited for medication injection pens, with a reusable pen cap being a possible configuration.

Moreover, the patent also outlines a method for managing medication therapy using a manual medication delivery device, involving receiving analyte data, detecting dosing events, storing relevant data, tracking time post-dosing, and providing dose recommendations based on the data and time elapsed. The method includes detecting capping or decapping events, utilizing sensors for dosing event detection, and communicating data with mobile devices. Additionally, a feature of the accessory involves determining the duration of time it is coupled to the medication delivery device, providing dose recommendations based on this duration, and issuing notifications for dosing events detected within specific time thresholds. This innovative approach aims to enhance medication management and therapy adherence for users of manual medication delivery devices, particularly medication injection pens, by leveraging data-driven recommendations and timely notifications.

To know more about GlobalData’s detailed insights on Bigfoot Biomedical, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.